Reference
Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia Internet Document : 26 May 2022. Available from: URL: https://www.gov.uk/drug-safety-update/denosumab-60mg-prolia-should-not-be-used-in-patients-under-18-years-due-to-the-risk-of-serious-hypercalcaemia
Rights and permissions
About this article
Cite this article
Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia. Reactions Weekly 1909, 3 (2022). https://doi.org/10.1007/s40278-022-16290-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-16290-8